Condition: Lung Neoplasm Malignant · Sponsor: Merck Sharp & Dohme LLC
Researchers want to learn if MK-1084, the study medicine, can treat advanced or metastatic non-squamous NSCLC. MK-1084 is a targeted therapy, which is a treatment that works to control how specific types of cancer cells grow and spread. The goals of this study are to learn: * About the safety of MK-1084 and if people tolerate it when taken with other treatments * How many people have the cancer respond (get smaller or go away) to the treatments
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Clermont Oncology Center ( Site 0041) | Clermont, Florida, United States | Recruiting |
| University of Illinois Hospital & Health Sciences System ( Site 0044) | Chicago, Illinois, United States | Recruiting |
| Providence Portland Medical Center ( Site 0043) | Portland, Oregon, United States | Recruiting |
| Providence Oncology and Hematology Care Clinic - Westside ( Site 0059) | Portland, Oregon, United States | Recruiting |
| Hospital São Lucas da PUCRS ( Site 0283) | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0282) | Barretos, São Paulo, Brazil | Recruiting |
| Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0286) | São José do Rio Preto, São Paulo, Brazil | Recruiting |
| Hospital Paulistano ( Site 0280) | São Paulo, São Paulo, Brazil | Recruiting |
| Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0162) | Santiago, Region M. de Santiago, Chile | Recruiting |
| FALP ( Site 0161) | Santiago, Region M. de Santiago, Chile | Recruiting |
| Bradfordhill ( Site 0160) | Santiago, Region M. de Santiago, Chile | Recruiting |
| Guangdong Provincial People s Hospital ( Site 0300) | Guangzhou, Guangdong, China | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07286149